A detailed history of Aquatic Capital Management LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Aquatic Capital Management LLC holds 75,900 shares of CYTK stock, worth $3.71 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
75,900
Previous 5,600 1255.36%
Holding current value
$3.71 Million
Previous $303,000 1222.44%
% of portfolio
0.11%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$51.22 - $60.16 $3.6 Million - $4.23 Million
70,300 Added 1255.36%
75,900 $4.01 Million
Q2 2024

Aug 14, 2024

BUY
$47.86 - $75.05 $268,016 - $420,280
5,600 New
5,600 $303,000
Q2 2023

Aug 14, 2023

BUY
$32.62 - $40.75 $127,217 - $158,925
3,900 New
3,900 $127,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.6B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.